NCT03316599 2021-08-03Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic CancerDana-Farber Cancer InstitutePhase 1 Completed26 enrolled
NCT00969410 2012-04-12A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver MetastasesAVEO Pharmaceuticals, Inc.Phase 1 Completed19 enrolled